QIAN Peng. Insulin autoantibody positive distribution and the changes of C peptide and related biochemical indices in patients with type 2 diabetes mellitus[J]. Laboratory Medicine, 2016, 31(1): 9-12.
IRVINE WJ,MCCALLUM CJ,GRAY RS,et al. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents[J]. Lancet,1977,1(8020):1025-1027.
2
PIPI E,MARKETOU M,TSIROGIANNI A. Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus[J]. World J Diabetes,2014,5(4):505-510.
3
ZAMPETTI S,CAMPAGNA G,TIBERTI C,et al. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up(NIRAD study 7)[J]. Eur J Endocrinol,2014,171(6): 697-704.
LI X,HUANG G,LIN J,et al. Variation of C peptide decay rate in diabetic patients with positive glutamic acid decarboxylase antibody: better discrimination with initial fasting C peptide[J]. BMC Endocr Disord,2013,13:10.
9
HERNANDEZ M,MOLLO A,MARSAL JR,et al. Insulin secretion in patients with latent autoimmune diabetes(LADA): half way between type 1 and type 2 diabetes: action LADA 9[J]. BMC Endocr Disord,2015,15:1.